作用机制 行为基底 修改 NMDA受体的正基调节器的作用机制
Elijah Z Ullman1, Riley E Perszyk1, Srinu Paladugu1
1Departments of Pharmacology and Chemical Biology, Emory School of Medicine (E.Z.U., R.E.P., S.F.T.) and Chemistry (S.P., R.G.F., N.S.A., L.J., D.C.L.), Emory University, Atlanta, Georgia.
Molecular pharmacology
|October 23, 2024
概括
像EU1622-240这样的阳性全调节剂通过增加开放概率和激动剂强度来增强N-甲基-D-酸盐受体 (NMDAR) 功能. 这些调节器通过启用独特的NMDAR门机制,为神经系统疾病提供了新的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 在中枢神经系统中,N-甲基-D-酸盐受体 (NMDARs) 对于刺激性神经传递和透性至关重要.
- NMDAR功能障碍与各种神经发育,神经精神和神经退行性疾病有关.
- 阳性全调节剂 (全调节剂) 为调节NMDAR功能提供了潜在的治疗策略.
研究的目的:
- 为了阐明EU1622-240的作用机制,一种代表性的[2,3-day]胺-4-one全调节剂.
- 调查EU1622-240如何调节NMDAR关,单通道特性和协激剂结合.
- 探索EU1622-240对与NMDAR功能障碍相关的疾病的治疗潜力.
主要方法:
- 在Xenopus卵细胞,人类胚胎细胞以及培养的小脑和皮质神经元中进行了电生理学记录.
- 通过测量当前反应,失活时间,开放概率,协激剂功率和单通道导电性来评估NMDAR功能.
- 对比了EU1622-240对单个激动剂 (谷氨酸或甘氨酸) 与两种联合激动剂对NMDAR激活的影响.
主要成果:
- 欧盟1622-240加强了NMDAR对和激动剂的当前反应,并减缓了停用.
- 基调节器增加了NMDAR的开放概率和协激剂的功效,同时减少了单通道导电.
- 欧盟1622-240促进了单独使用谷氨酸或甘氨酸激活NMDAR,从而产生具有独特孔状性质和Mg2+敏感性的道,而不是由两种协兴剂激活的道.
结论:
- 欧盟1622-240证明了对NMDARs的一种全调节的新机制.
- 这些发现揭示了由谷氨酸和甘氨酸结合控制的独特的关门步骤,由1622系列全调节器调节.
- 欧盟1622-240的独特特性表明在神经疾病中调节神经电路功能的显著治疗机会.
相关概念视频
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.1K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.1K
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
1.7K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
1.7K
01:19Ligand-gated Ion Channels
12.2K
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
12.2K
01:26Neurochemical Transmission: Sites of Drug Action
2.1K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.1K
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
101
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
101
01:25Long-term Potentiation
2.7K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
Hebbian LTP
LTP can occur when...
2.7K